Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 or 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported):
June 8, 2004 (June 7, 2004)
Advanced Neuromodulation Systems, Inc.
Texas | 0-10521 | 75-1646002 | ||
(State or Other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
6501 Windcrest Drive, Suite 100
Plano, Texas 75024
Registrant’s telephone number, including area code:
(972) 309-8000
Item 9. “Regulation FD Disclosure.” | ||||||||
SIGNATURES | ||||||||
INDEX TO EXHIBITS | ||||||||
Press Release |
Table of Contents
Item 9. “Regulation FD Disclosure.”
On June 7, 2004, we issued a press release that contained the comments of our President and Chief Executive Officer, Christopher G. Chavez, on Boston Scientific Corporation’s announcement that is acquiring Advanced Bionics Corporation. Advanced Bionics Corporation recently announced that it has received FDA approval for a rechargeable spinal cord stimulation system, and that it expects to enter the spinal cord stimulation market for the treatment of chronic pain sometime during the third quarter of 2004. A copy of the press release is attached as Exhibit 99.1.
This press release shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act.
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Dated: June 8, 2004
ADVANCED NEUROMODULATION SYSTEMS, INC. | ||||
By: | /s/ F. Robert Merrill III | |||
Name: | F. Robert Merrill III | |||
Title: | Executive Vice President, Finance, Chief Financial Officer and Treasurer | |||